Table 1 Demographic and clinicopathological data of breast carcinoma patients
Parameter | Breast cancer | Benign | Healthy | P value |
|---|---|---|---|---|
Number | 80 | 30 | 20 | – |
Age (years, mean ± SD) | 52.4 ± 9.1 | 52.0 ± 9.3 | 51.5 ± 8.9 | 0.923a |
Menopause, number (percentage) | ||||
 Post-menopausal | 35 (43.8%) | 13 (43.3%) | 8 (40%) | 0.955b |
 Pre-menopausal | 45 (56.2%) | 17 (56.7%) | 12 (60%) | |
Tumor invasion number (percentage) | ||||
 In situ | 32(40%) | – | – | – |
 Invasive | 48(60%) | – | – | – |
Tumor depth (stage) | ||||
 Early (T ≤ 2) | 35(43.8%) | – | – | – |
 Late (T > 2) | 45 (56.2%) | – | – | – |
Tumor grade | ||||
 Low (G1) | 30(37.5%) | – | – | – |
 High (G2–3) | 50 (62.5%) | – | – | – |
Lymph node invasion | ||||
 Negative | 42 (52.5%) | – | – | – |
 Positive | 38 (47.5%) | – | – | – |
Estrogen receptor (ER) | ||||
 Negative | 40 (50%) | – | – | – |
 Positive | 40 (50%) | – | – | – |
Progesterone receptor (PgR) | ||||
 Negative | 28 (35%) | – | – | – |
 Positive | 52 (65%) | – | – | – |
HER-2/neu status | ||||
 Negative | 28 (35%) | – | – | – |
 Positive | 52 (65%) | – | – | – |